Kushner is also wary of compounded versions, now that shortages have eased, because there's no way to be sure what's in the vial
Tirzepatide achieved even greater results , with some trial participants losing over 20 percent of their starting weight
July 01, 2025 / 09:14 IST Representative image Discover the latest Business News, Sensex, and Nifty updates
Ethics statement Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements
The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications. Also Read: Generic Semaglutide launches in India after patent expiry Side effects range from mild to severe Common side effects include nausea, vomiting, diarrhea, constipation, and loss of appetite
In individuals with obesity, particularly those with concomitant metabolic derangements, GLP-1 agonists offer a holistic therapeutic approach by addressing both weight and metabolic parameters